BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Amraei R, Rahimi N. COVID-19, Renin-Angiotensin System and Endothelial Dysfunction. Cells. 2020;9. [PMID: 32660065 DOI: 10.3390/cells9071652] [Cited by in Crossref: 68] [Cited by in F6Publishing: 63] [Article Influence: 34.0] [Reference Citation Analysis]
Number Citing Articles
1 Okada Y, Yoshimura K, Toya S, Tsuchimochi M. Pathogenesis of taste impairment and salivary dysfunction in COVID-19 patients. Jpn Dent Sci Rev 2021;57:111-22. [PMID: 34257762 DOI: 10.1016/j.jdsr.2021.07.001] [Reference Citation Analysis]
2 Varghese E, Samuel SM, Liskova A, Kubatka P, Büsselberg D. Diabetes and coronavirus (SARS-CoV-2): Molecular mechanism of Metformin intervention and the scientific basis of drug repurposing. PLoS Pathog 2021;17:e1009634. [PMID: 34157054 DOI: 10.1371/journal.ppat.1009634] [Reference Citation Analysis]
3 Goncharov NV, Vasilyev KA, Kudryavtsev IV, Avdonin PP, Belinskaia DA, Stukova MA, Shamova OV, Avdonin PV. Experimental Search for New Means of Pathogenetic Therapy COVID-19: Inhibitor of H2-Receptors Famotidine Increases the Effect of Oseltamivir on Survival and Immune Status of Mice Infected by A/PR/8/34 (H1N1). J Evol Biochem Phys 2022;58:230-46. [DOI: 10.1134/s0022093022010203] [Reference Citation Analysis]
4 Kaur S, Tripathi DM, Yadav A. The Enigma of Endothelium in COVID-19. Front Physiol 2020;11:989. [PMID: 32848893 DOI: 10.3389/fphys.2020.00989] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 14.0] [Reference Citation Analysis]
5 Emadi-Baygi M, Ehsanifard M, Afrashtehpour N, Norouzi M, Joz-Abbasalian Z. Corona Virus Disease 2019 (COVID-19) as a System-Level Infectious Disease With Distinct Sex Disparities. Front Immunol 2021;12:778913. [PMID: 34912345 DOI: 10.3389/fimmu.2021.778913] [Reference Citation Analysis]
6 Lin L, Chen X, Chen J, Pan X, Xia P, Lin H, Du H. The predictive value of serum level of cystatin C for COVID-19 severity. Sci Rep 2021;11:21964. [PMID: 34754069 DOI: 10.1038/s41598-021-01570-2] [Reference Citation Analysis]
7 Amar J, Touront N, Ciron AM, Pendaries C. Interactions between hypertension and inflammatory tone and the effect on blood pressure and outcomes in patients with COVID-19. J Clin Hypertens (Greenwich) 2021;23:238-44. [PMID: 33491247 DOI: 10.1111/jch.14137] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
8 Rahimi N. C-type Lectin CD209L/L-SIGN and CD209/DC-SIGN: Cell Adhesion Molecules Turned to Pathogen Recognition Receptors. Biology (Basel) 2020;10:1. [PMID: 33375175 DOI: 10.3390/biology10010001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
9 Wicik Z, Eyileten C, Jakubik D, Simões SN, Martins DC Jr, Pavão R, Siller-Matula JM, Postula M. ACE2 Interaction Networks in COVID-19: A Physiological Framework for Prediction of Outcome in Patients with Cardiovascular Risk Factors. J Clin Med 2020;9:E3743. [PMID: 33233425 DOI: 10.3390/jcm9113743] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
10 Bargehr J, Rericha P, Petchey A, Colzani M, Moule G, Malgapo MC, Rassl D, Tarkin J, Mellor G, Sampaziotis F, Brevini T, Gambardella L, Bennett MR, Sinha S. Cardiovascular ACE2 receptor expression in patients undergoing heart transplantation. ESC Heart Fail 2021. [PMID: 34390216 DOI: 10.1002/ehf2.13528] [Reference Citation Analysis]
11 Asl SH, Nikfarjam S, Majidi Zolbanin N, Nassiri R, Jafari R. Immunopharmacological perspective on zinc in SARS-CoV-2 infection. Int Immunopharmacol 2021;96:107630. [PMID: 33882442 DOI: 10.1016/j.intimp.2021.107630] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
12 Fodor A, Tiperciuc B, Login C, Orasan OH, Lazar AL, Buchman C, Hanghicel P, Sitar-Taut A, Suharoschi R, Vulturar R, Cozma A. Endothelial Dysfunction, Inflammation, and Oxidative Stress in COVID-19-Mechanisms and Therapeutic Targets. Oxid Med Cell Longev 2021;2021:8671713. [PMID: 34457119 DOI: 10.1155/2021/8671713] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
13 Kamel MH, Yin W, Zavaro C, Francis JM, Chitalia VC. Hyperthrombotic Milieu in COVID-19 Patients. Cells 2020;9:E2392. [PMID: 33142844 DOI: 10.3390/cells9112392] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
14 Cramer J, Lakkaichi A, Aliu B, Jakob RP, Klein S, Cattaneo I, Jiang X, Rabbani S, Schwardt O, Zimmer G, Ciancaglini M, Abreu Mota T, Maier T, Ernst B. Sweet Drugs for Bad Bugs: A Glycomimetic Strategy against the DC-SIGN-Mediated Dissemination of SARS-CoV-2. J Am Chem Soc 2021;143:17465-78. [PMID: 34652144 DOI: 10.1021/jacs.1c06778] [Reference Citation Analysis]
15 García-Ayllón MS, Moreno-Pérez O, García-Arriaza J, Ramos-Rincón JM, Cortés-Gómez MÁ, Brinkmalm G, Andrés M, León-Ramírez JM, Boix V, Gil J, Zetterberg H, Esteban M, Merino E, Sáez-Valero J. Plasma ACE2 species are differentially altered in COVID-19 patients. FASEB J 2021;35:e21745. [PMID: 34191346 DOI: 10.1096/fj.202100051R] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Körner RW, Majjouti M, Alcazar MAA, Mahabir E. Of Mice and Men: The Coronavirus MHV and Mouse Models as a Translational Approach to Understand SARS-CoV-2. Viruses 2020;12:E880. [PMID: 32806708 DOI: 10.3390/v12080880] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 10.5] [Reference Citation Analysis]
17 Tang Q, Gao L, Tong Z, Li W. Hyperlipidemia, COVID-19 and acute pancreatitis: a tale of three entities. Am J Med Sci 2022:S0002-9629(22)00132-X. [PMID: 35381217 DOI: 10.1016/j.amjms.2022.03.007] [Reference Citation Analysis]
18 Faour WH, Choaib A, Issa E, Choueiry FE, Shbaklo K, Alhajj M, Sawaya RT, Harhous Z, Alefishat E, Nader M. Mechanisms of COVID-19-induced kidney injury and current pharmacotherapies. Inflamm Res 2021. [PMID: 34802072 DOI: 10.1007/s00011-021-01520-8] [Reference Citation Analysis]
19 Medvedev VE, Frolova VI, Gushanskaya EV, Kotova OV, Zuikova NL, Palin AV. [Astenic disorders within the framework of post-covid syndrome]. Zh Nevrol Psikhiatr Im S S Korsakova 2021;121:152-8. [PMID: 34037369 DOI: 10.17116/jnevro2021121041152] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Amraei R, Yin W, Napoleon MA, Suder EL, Berrigan J, Zhao Q, Olejnik J, Chandler KB, Xia C, Feldman J, Hauser BM, Caradonna TM, Schmidt AG, Gummuluru S, Muhlberger E, Chitalia V, Costello CE, Rahimi N. CD209L/L-SIGN and CD209/DC-SIGN act as receptors for SARS-CoV-2. bioRxiv 2021:2020. [PMID: 32607506 DOI: 10.1101/2020.06.22.165803] [Cited by in Crossref: 53] [Cited by in F6Publishing: 11] [Article Influence: 53.0] [Reference Citation Analysis]
21 Bai Z, Li P, Wen J, Han Y, Cui Y, Zhou Y, Shi Z, Chen S, Li Q, Zhao X, Wang Z, Li R, Guo Y, Zhan X, Xu G, Ding K, Wang J, Xiao X. Inhibitory effects and mechanisms of the anti-covid-19 traditional Chinese prescription, Keguan-1, on acute lung injury. J Ethnopharmacol 2021;285:114838. [PMID: 34788645 DOI: 10.1016/j.jep.2021.114838] [Reference Citation Analysis]
22 Ambrosino P, Calcaterra I, Molino A, Moretta P, Lupoli R, Spedicato GA, Papa A, Motta A, Maniscalco M, Di Minno MND. Persistent Endothelial Dysfunction in Post-Acute COVID-19 Syndrome: A Case-Control Study. Biomedicines 2021;9:957. [PMID: 34440161 DOI: 10.3390/biomedicines9080957] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Preissner KT, Fischer S, Deindl E. Extracellular RNA as a Versatile DAMP and Alarm Signal That Influences Leukocyte Recruitment in Inflammation and Infection. Front Cell Dev Biol 2020;8:619221. [PMID: 33392206 DOI: 10.3389/fcell.2020.619221] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
24 Podzolkov VI, Tarzimanova AI. The Importance of Antihypertensive and Lipid-Lowering Therapy in the Treatment of Patients with a New Coronavirus Infection COVID-19. Racionalʹnaâ farmakoterapiâ v kardiologii 2021;17:310-4. [DOI: 10.20996/1819-6446-2021-03-01] [Reference Citation Analysis]
25 Fang W, Jiang J, Su L, Shu T, Liu H, Lai S, Ghiladi RA, Wang J. The role of NO in COVID-19 and potential therapeutic strategies. Free Radic Biol Med 2021;163:153-62. [PMID: 33347987 DOI: 10.1016/j.freeradbiomed.2020.12.008] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 10.5] [Reference Citation Analysis]
26 Verhoef PA, Kannan S, Sturgill JL, Tucker EW, Morris PE, Miller AC, Sexton TR, Koyner JL, Hejal R, Brakenridge SC, Moldawer LL, Hotchkiss RS, Blood TM, Mazer MB, Bolesta S, Alexander SA, Armaignac DL, Shein SL, Jones C, Hoemann CD, Doctor A, Friess SH, Parker RI, Rotta AT, Remy KE. Severe Acute Respiratory Syndrome-Associated Coronavirus 2 Infection and Organ Dysfunction in the ICU: Opportunities for Translational Research. Crit Care Explor 2021;3:e0374. [PMID: 33786450 DOI: 10.1097/CCE.0000000000000374] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
27 Yadav DK, Singh DD, Han I, Kumar Y, Choi EH. Current Potential Therapeutic Approaches against SARS-CoV-2: A Review. Biomedicines 2021;9:1620. [PMID: 34829850 DOI: 10.3390/biomedicines9111620] [Reference Citation Analysis]
28 Zhang S, Liang Y, Li L, Chen Y, Wu P, Wei D. Succinate: A Novel Mediator to Promote Atherosclerotic Lesion Progression. DNA Cell Biol 2022. [PMID: 35138943 DOI: 10.1089/dna.2021.0345] [Reference Citation Analysis]
29 Wang S, Tan Y, Yang T, Liu C, Li R. Pulmonary AngII promotes LPS-induced lung inflammation by regulating microRNA-143. Cytotechnology 2021;:1-10. [PMID: 34493899 DOI: 10.1007/s10616-021-00493-0] [Reference Citation Analysis]
30 Golota AS, Kamilova TA, Shneider OV, Vologzhanin DA, Sherbak SG. Pathogenesis of the initial stages of severe COVID-19. Journal of Clinical Practice 2021;12:83-102. [DOI: 10.17816/clinpract71351] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
31 Sfera A, Osorio C, Zapata Martín Del Campo CM, Pereida S, Maurer S, Maldonado JC, Kozlakidis Z. Endothelial Senescence and Chronic Fatigue Syndrome, a COVID-19 Based Hypothesis. Front Cell Neurosci 2021;15:673217. [PMID: 34248502 DOI: 10.3389/fncel.2021.673217] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
32 Krothapalli N, Jacob J. A Rare Case of Acute Mesenteric Ischemia in the Setting of COVID-19 Infection. Cureus 2021;13:e14174. [PMID: 33936885 DOI: 10.7759/cureus.14174] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
33 Lugnier C, Al-Kuraishy HM, Rousseau E. PDE4 inhibition as a therapeutic strategy for improvement of pulmonary dysfunctions in Covid-19 and cigarette smoking. Biochem Pharmacol 2021;185:114431. [PMID: 33515531 DOI: 10.1016/j.bcp.2021.114431] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 9.0] [Reference Citation Analysis]
34 Paneroni M, Pasini E, Vitacca M, Scalvini S, Comini L, Pedrinolla A, Venturelli M. Altered Vascular Endothelium-Dependent Responsiveness in Frail Elderly Patients Recovering from COVID-19 Pneumonia: Preliminary Evidence. J Clin Med 2021;10:2558. [PMID: 34207876 DOI: 10.3390/jcm10122558] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
35 Andrew M, Jayaraman G. Marine sulfated polysaccharides as potential antiviral drug candidates to treat Corona Virus disease (COVID-19). Carbohydr Res 2021;505:108326. [PMID: 34015720 DOI: 10.1016/j.carres.2021.108326] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
36 Madureira G, Soares R. The misunderstood link between SARS-CoV-2 and angiogenesis. A narrative review. Pulmonology 2021:S2531-0437(21)00160-4. [PMID: 34593362 DOI: 10.1016/j.pulmoe.2021.08.004] [Reference Citation Analysis]
37 Wang J, Zhao H, An Y. ACE2 Shedding and the Role in COVID-19. Front Cell Infect Microbiol 2022;11:789180. [DOI: 10.3389/fcimb.2021.789180] [Reference Citation Analysis]
38 Hage R, Steinack C, Gautschi F, Schuurmans MM. Transplant Drugs against SARS, MERS and COVID-19. Transplantology 2020;1:71-84. [DOI: 10.3390/transplantology1020007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
39 Akhter MS, Hamali HA, Mobarki AA, Rashid H, Oldenburg J, Biswas A. SARS-CoV-2 Infection: Modulator of Pulmonary Embolism Paradigm. J Clin Med 2021;10:1064. [PMID: 33806540 DOI: 10.3390/jcm10051064] [Reference Citation Analysis]
40 Barbui T, De Stefano V, Alvarez-Larran A, Iurlo A, Masciulli A, Carobbio A, Ghirardi A, Ferrari A, Cancelli V, Elli EM, Andrade-Campos MM, Kabat MG, Kiladjian JJ, Palandri F, Benevolo G, Garcia-Gutierrez V, Fox ML, Foncillas MA, Morcillo CM, Rumi E, Osorio S, Papadopoulos P, Bonifacio M, Cervantes KSQ, Serrano MS, Carreno-Tarragona G, Sobas MA, Lunghi F, Patriarca A, Elorza BN, Angona A, Mazo EM, Koschmieder S, Carli G, Cuevas B, Hernandez-Boluda JC, Abadia EL, Cirici BX, Guglielmelli P, Garrote M, Cattaneo D, Daffini R, Cavalca F, Bellosillo B, Benajiba L, Curto-Garcia N, Bellini M, Betti S, Harrison C, Rambaldi A, Vannucchi AM. Among classic myeloproliferative neoplasms, essential thrombocythemia is associated with the greatest risk of venous thromboembolism during COVID-19. Blood Cancer J 2021;11:21. [PMID: 33563901 DOI: 10.1038/s41408-021-00417-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
41 Galán M, Jiménez-Altayó F. Small Resistance Artery Disease and ACE2 in Hypertension: A New Paradigm in the Context of COVID-19. Front Cardiovasc Med 2020;7:588692. [PMID: 33195477 DOI: 10.3389/fcvm.2020.588692] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
42 Thakur S, Mayank, Sarkar B, Ansari AJ, Khandelwal A, Arya A, Poduri R, Joshi G. Exploring the magic bullets to identify Achilles' heel in SARS-CoV-2: Delving deeper into the sea of possible therapeutic options in Covid-19 disease: An update. Food Chem Toxicol 2021;147:111887. [PMID: 33253764 DOI: 10.1016/j.fct.2020.111887] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
43 Ionescu M, Stoian AP, Rizzo M, Serban D, Nuzzo D, Mazilu L, Suceveanu AI, Dascalu AM, Parepa IR. The Role of Endothelium in COVID-19. Int J Mol Sci 2021;22:11920. [PMID: 34769350 DOI: 10.3390/ijms222111920] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
44 Nicolas-Jilwan M, Almaghrabi RS. Diffuse necrotising leukoencephalopathy with microhaemorrhages in a patient with severe COVID-19 disease. Neuroradiol J 2020;33:528-31. [PMID: 32928038 DOI: 10.1177/1971400920959324] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
45 Barros A, Queiruga-Piñeiro J, Lozano-Sanroma J, Alcalde I, Gallar J, Fernández-Vega Cueto L, Alfonso JF, Quirós LM, Merayo-Lloves J. Small fiber neuropathy in the cornea of Covid-19 patients associated with the generation of ocular surface disease. Ocul Surf 2021;23:40-8. [PMID: 34781021 DOI: 10.1016/j.jtos.2021.10.010] [Reference Citation Analysis]
46 Zare Karizak S, Kashef M. Hematologic Disorders of COVID-19 and Appropriate Intensity of Exercise in Coronavirus Prevalence Period. Asian J Sports Med 2021;12. [DOI: 10.5812/asjsm.113016] [Reference Citation Analysis]
47 Bajaj V, Gadi N, Spihlman AP, Wu SC, Choi CH, Moulton VR. Aging, Immunity, and COVID-19: How Age Influences the Host Immune Response to Coronavirus Infections? Front Physiol 2020;11:571416. [PMID: 33510644 DOI: 10.3389/fphys.2020.571416] [Cited by in Crossref: 40] [Cited by in F6Publishing: 46] [Article Influence: 40.0] [Reference Citation Analysis]
48 Rotoli BM, Barilli A, Visigalli R, Ferrari F, Dall'Asta V. Endothelial Cell Activation by SARS-CoV-2 Spike S1 Protein: A Crosstalk between Endothelium and Innate Immune Cells. Biomedicines 2021;9:1220. [PMID: 34572407 DOI: 10.3390/biomedicines9091220] [Reference Citation Analysis]
49 Bisceglia I, Gabrielli D, Canale ML, Gallucci G, Parrini I, Turazza FM, Russo G, Maurea N, Quagliariello V, Lestuzzi C, Oliva S, Di Fusco SA, Lucà F, Tarantini L, Trambaiolo P, Gulizia MM, Colivicchi F. ANMCO POSITION PAPER: cardio-oncology in the COVID era (CO and CO). Eur Heart J Suppl 2021;23:C128-53. [PMID: 34456641 DOI: 10.1093/eurheartj/suab067] [Reference Citation Analysis]
50 Hu S, Yin F, Nie L, Wang Y, Qin J, Chen J. Estrogen and Estrogen Receptor Modulators: Potential Therapeutic Strategies for COVID-19 and Breast Cancer. Front Endocrinol 2022;13:829879. [DOI: 10.3389/fendo.2022.829879] [Reference Citation Analysis]
51 Geronikolou SA, Takan I, Pavlopoulou A, Mantzourani M, Chrousos GP. Thrombocytopenia in COVID‑19 and vaccine‑induced thrombotic thrombocytopenia. Int J Mol Med 2022;49:35. [PMID: 35059730 DOI: 10.3892/ijmm.2022.5090] [Reference Citation Analysis]
52 Capaccione KM, Yang H, West E, Patel H, Ma H, Patel S, Fruauff A, Loeb G, Maddocks A, Borowski A, Lala S, Nguyen P, Lignelli A, D'souza B, Desperito E, Ruzal-Shapiro C, Salvatore MM. Pathophysiology and Imaging Findings of COVID-19 Infection: An Organ-system Based Review. Acad Radiol 2021;28:595-607. [PMID: 33583712 DOI: 10.1016/j.acra.2021.01.022] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
53 Sadeghmousavi S, Rezaei N. COVID-19 infection and stroke risk. Rev Neurosci 2021;32:341-9. [PMID: 33580645 DOI: 10.1515/revneuro-2020-0066] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
54 Amraei R, Xia C, Olejnik J, White MR, Napoleon MA, Lotfollahzadeh S, Hauser BM, Schmidt AG, Chitalia V, Mühlberger E, Costello CE, Rahimi N. Extracellular vimentin is an attachment factor that facilitates SARS-CoV-2 entry into human endothelial cells. Proc Natl Acad Sci USA 2022;119:e2113874119. [DOI: 10.1073/pnas.2113874119] [Reference Citation Analysis]
55 Soni B, Singh S. COVID-19 co-infection mathematical model as guided through signaling structural framework. Comput Struct Biotechnol J 2021;19:1672-83. [PMID: 33815692 DOI: 10.1016/j.csbj.2021.03.028] [Reference Citation Analysis]
56 Zanza C, Tassi MF, Romenskaya T, Piccolella F, Abenavoli L, Franceschi F, Piccioni A, Ojetti V, Saviano A, Canonico B, Montanari M, Zamai L, Artico M, Robba C, Racca F, Longhitano Y. Lock, Stock and Barrel: Role of Renin-Angiotensin-Aldosterone System in Coronavirus Disease 2019. Cells 2021;10:1752. [PMID: 34359922 DOI: 10.3390/cells10071752] [Reference Citation Analysis]
57 Buso G, Becchetti C, Berzigotti A. Acute splanchnic vein thrombosis in patients with COVID-19: A systematic review. Dig Liver Dis 2021;53:937-49. [PMID: 34120860 DOI: 10.1016/j.dld.2021.05.021] [Reference Citation Analysis]
58 Mesquida J, Caballer A, Cortese L, Vila C, Karadeniz U, Pagliazzi M, Zanoletti M, Pacheco AP, Castro P, García-de-Acilu M, Mesquita RC, Busch DR, Durduran T; HEMOCOVID-19 Consortium. Peripheral microcirculatory alterations are associated with the severity of acute respiratory distress syndrome in COVID-19 patients admitted to intermediate respiratory and intensive care units. Crit Care 2021;25:381. [PMID: 34749792 DOI: 10.1186/s13054-021-03803-2] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
59 Tarnawski AS, Ahluwalia A. Endothelial cells and blood vessels are major targets for COVID-19-induced tissue injury and spreading to various organs. World J Gastroenterol 2022;28:275-89. [PMID: 35110950 DOI: 10.3748/wjg.v28.i3.275] [Reference Citation Analysis]
60 Wang J, Wang Y, Liu B, He Y, Li Z, Zhao Q, Nan Y, Wu C. Porcine Epidemic Diarrhea Virus Envelope Protein Blocks SLA-DR Expression in Barrow-Derived Dendritic Cells by Inhibiting Promoters Activation. Front Immunol 2021;12:741425. [PMID: 34858400 DOI: 10.3389/fimmu.2021.741425] [Reference Citation Analysis]
61 Tang X, Zheng F. A review of ischemic stroke in COVID-19: currently known pathophysiological mechanisms. Neurol Sci 2021. [PMID: 34671854 DOI: 10.1007/s10072-021-05679-0] [Reference Citation Analysis]
62 Iftikhar S, Rehman AU, Ameer MZ, Nawaz A, Aemaz Ur Rehman M, Farooq H, Asmar A, Ebaad Ur Rehman M. The association of posterior reversible encephalopathy syndrome with COVID-19: A systematic review. Ann Med Surg (Lond) 2021;72:103080. [PMID: 34840779 DOI: 10.1016/j.amsu.2021.103080] [Reference Citation Analysis]
63 Amri N, Bégin R, Tessier N, Vachon L, Villeneuve L, Bégin P, Bazin R, Loubaki L, Martel C. Use of Early Donated COVID-19 Convalescent Plasma Is Optimal to Preserve the Integrity of Lymphatic Endothelial Cells. Pharmaceuticals 2022;15:365. [DOI: 10.3390/ph15030365] [Reference Citation Analysis]
64 Li XT, Zhang MW, Zhang ZZ, Cao YD, Liu XY, Miao R, Xu Y, Song XF, Song JW, Liu Y, Xu YL, Li J, Dong Y, Zhong JC. Abnormal apelin-ACE2 and SGLT2 signaling contribute to adverse cardiorenal injury in patients with COVID-19. Int J Cardiol 2021;336:123-9. [PMID: 34000358 DOI: 10.1016/j.ijcard.2021.05.029] [Reference Citation Analysis]
65 Vassiliou AG, Kotanidou A, Dimopoulou I, Orfanos SE. Endothelial Damage in Acute Respiratory Distress Syndrome. Int J Mol Sci 2020;21:E8793. [PMID: 33233715 DOI: 10.3390/ijms21228793] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
66 Deng H, Tang TX, Chen D, Tang LS, Yang XP, Tang ZH. Endothelial Dysfunction and SARS-CoV-2 Infection: Association and Therapeutic Strategies. Pathogens 2021;10:582. [PMID: 34064553 DOI: 10.3390/pathogens10050582] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
67 Amraei R, Yin W, Napoleon MA, Suder EL, Berrigan J, Zhao Q, Olejnik J, Chandler KB, Xia C, Feldman J, Hauser BM, Caradonna TM, Schmidt AG, Gummuluru S, Mühlberger E, Chitalia V, Costello CE, Rahimi N. CD209L/L-SIGN and CD209/DC-SIGN Act as Receptors for SARS-CoV-2. ACS Cent Sci 2021;7:1156-65. [PMID: 34341769 DOI: 10.1021/acscentsci.0c01537] [Cited by in Crossref: 1] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
68 Rasmi Y, Babaei G, Nisar MF, Noreen H, Gholizadeh-Ghaleh Aziz S. Revealed pathophysiological mechanisms of crosslinking interaction of affected vital organs in COVID-19. Comp Clin Path 2021;:1-17. [PMID: 34539310 DOI: 10.1007/s00580-021-03269-2] [Reference Citation Analysis]
69 Liu A, Raja xavier J, Singh Y, Brucker SY, Salker MS. Molecular and Physiological Aspects of SARS-CoV-2 Infection in Women and Pregnancy. Front Glob Womens Health 2022;3:756362. [DOI: 10.3389/fgwh.2022.756362] [Reference Citation Analysis]
70 Medina-Enríquez MM, Lopez-León S, Carlos-Escalante JA, Aponte-Torres Z, Cuapio A, Wegman-Ostrosky T. ACE2: the molecular doorway to SARS-CoV-2. Cell Biosci 2020;10:148. [PMID: 33380340 DOI: 10.1186/s13578-020-00519-8] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 10.0] [Reference Citation Analysis]
71 Cramer J, Aliu B, Jiang X, Sharpe T, Pang L, Hadorn A, Rabbani S, Ernst B. Poly-l-lysine Glycoconjugates Inhibit DC-SIGN-mediated Attachment of Pandemic Viruses. ChemMedChem 2021;16:2345-53. [PMID: 34061468 DOI: 10.1002/cmdc.202100348] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
72 Graciano-Machuca O, Villegas-Rivera G, López-Pérez I, Macías-Barragán J, Sifuentes-Franco S. Multisystem Inflammatory Syndrome in Children (MIS-C) Following SARS-CoV-2 Infection: Role of Oxidative Stress. Front Immunol 2021;12:723654. [PMID: 34737740 DOI: 10.3389/fimmu.2021.723654] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
73 Yoganandamoorthy S, Munasinghe MADSN, Wanigasuriya LVU, Priyankara MKK, Jayasinghe S. Non-invasive assessment of endothelial dysfunction: A novel method to predict severe COVID-19? Med Hypotheses 2020;144:110229. [PMID: 33254535 DOI: 10.1016/j.mehy.2020.110229] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
74 Ragusa R, Basta G, Del Turco S, Caselli C. A possible role for ST2 as prognostic biomarker for COVID-19. Vascul Pharmacol 2021;138:106857. [PMID: 33746068 DOI: 10.1016/j.vph.2021.106857] [Cited by in Crossref: 5] [Article Influence: 5.0] [Reference Citation Analysis]
75 Prasad M, Leon M, Lerman LO, Lerman A. Viral Endothelial Dysfunction: A Unifying Mechanism for COVID-19. Mayo Clin Proc 2021;96:3099-108. [PMID: 34863398 DOI: 10.1016/j.mayocp.2021.06.027] [Reference Citation Analysis]
76 Fogacci S, Fogacci F, Favari E, Toth PP, Borghi C, Cicero AFG. Management of pregnancy-related hypertensive disorders in patients infected with SARS CoV-2: pharmacological and clinical issues. Eur Heart J Cardiovasc Pharmacother 2021;7:346-51. [PMID: 33155016 DOI: 10.1093/ehjcvp/pvaa105] [Reference Citation Analysis]
77 Matucci-Cerinic M, Hughes M, Taliani G, Kahaleh B. Similarities between COVID-19 and systemic sclerosis early vasculopathy: A "viral" challenge for future research in scleroderma. Autoimmun Rev 2021;20:102899. [PMID: 34274540 DOI: 10.1016/j.autrev.2021.102899] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
78 Pfeiffer AF, James R, Neuhoff BK, Pfeiffer WB, Lowery DR, Rizvi SAA. The Deleterious Effects of COVID-19 in the Peripartum Period: A Case Report. Pediatr Rep 2021;13:334-9. [PMID: 34208425 DOI: 10.3390/pediatric13020041] [Reference Citation Analysis]
79 Fakhri S, Piri S, Majnooni MB, Farzaei MH, Echeverría J. Targeting Neurological Manifestations of Coronaviruses by Candidate Phytochemicals: A Mechanistic Approach. Front Pharmacol 2020;11:621099. [PMID: 33708124 DOI: 10.3389/fphar.2020.621099] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
80 Steckelings UM, Sumners C. Correcting the imbalanced protective RAS in COVID-19 with angiotensin AT2-receptor agonists. Clin Sci (Lond) 2020;134:2987-3006. [PMID: 33210709 DOI: 10.1042/CS20200922] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 8.0] [Reference Citation Analysis]
81 Sciberras J, Camilleri LM, Cuschieri S. The burden of type 2 diabetes pre-and during the COVID-19 pandemic - a review. J Diabetes Metab Disord 2020;:1-9. [PMID: 33102262 DOI: 10.1007/s40200-020-00656-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
82 Norooznezhad AH, Mansouri K. Endothelial cell dysfunction, coagulation, and angiogenesis in coronavirus disease 2019 (COVID-19). Microvasc Res 2021;137:104188. [PMID: 34022205 DOI: 10.1016/j.mvr.2021.104188] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
83 Muhamad SA, Ugusman A, Kumar J, Skiba D, Hamid AA, Aminuddin A. COVID-19 and Hypertension: The What, the Why, and the How. Front Physiol 2021;12:665064. [PMID: 34012410 DOI: 10.3389/fphys.2021.665064] [Reference Citation Analysis]
84 Bello B, Useh U. COVID-19: Are Non-Communicable Diseases Risk Factors for Its Severity? Am J Health Promot 2021;35:720-9. [PMID: 33576237 DOI: 10.1177/0890117121990518] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
85 Wendel S, Fontão-Wendel R, Fachini R, Candelaria G, Scuracchio P, Achkar R, Brito M, Reis LF, Camargo A, Amano M, Machado R, Araujo D, Soares C, Durigon E. A longitudinal study of convalescent plasma (CCP) donors and correlation of ABO group, initial neutralizing antibodies (nAb), and body mass index (BMI) with nAb and anti-nucleocapsid (NP) SARS-CoV-2 antibody kinetics: Proposals for better quality of CCP collections. Transfusion 2021;61:1447-60. [PMID: 33604884 DOI: 10.1111/trf.16323] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
86 Popadic V, Klasnja S, Milic N, Rajovic N, Aleksic A, Milenkovic M, Crnokrak B, Balint B, Todorovic-Balint M, Mrda D, Zdravkovic D, Toskovic B, Brankovic M, Markovic O, Bjekic-Macut J, Djuran P, Memon L, Brajkovic M, Todorovic Z, Hadzi-Djokic J, Jovanovic I, Nikolic D, Zdravkovic M. Predictors of Mortality in Critically Ill COVID-19 Patients Demanding High Oxygen Flow: A Thin Line between Inflammation, Cytokine Storm, and Coagulopathy. Oxid Med Cell Longev 2021;2021:6648199. [PMID: 33968298 DOI: 10.1155/2021/6648199] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
87 Xia D, Yao R, Wang S, Chen G, Wang Y. Mapping Trends and Hotspots Regarding Clinical Research on COVID-19: A Bibliometric Analysis of Global Research. Front Public Health 2021;9:713487. [PMID: 34497794 DOI: 10.3389/fpubh.2021.713487] [Reference Citation Analysis]
88 Unudurthi SD, Luthra P, Bose RJC, McCarthy JR, Kontaridis MI. Cardiac inflammation in COVID-19: Lessons from heart failure. Life Sci 2020;260:118482. [PMID: 32971105 DOI: 10.1016/j.lfs.2020.118482] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 11.5] [Reference Citation Analysis]
89 Shen L, Qiu L, Wang L, Huang H, Liu D, Xiao Y, Liu Y, Jin J, Liu X, Wang DW, He B, Zhou N. Statin Use and In-hospital Mortality in Patients with COVID-19 and Coronary Heart Disease. Sci Rep 2021;11:23874. [PMID: 34903765 DOI: 10.1038/s41598-021-02534-2] [Reference Citation Analysis]
90 Grygiel-Górniak B, Shaikh O, Kumar NN, Hsu SH, Samborski W. Use of the rheumatic drug tocilizumab for treatment of SARS-CoV-2 patients. Reumatologia 2021;59:252-9. [PMID: 34538956 DOI: 10.5114/reum.2021.108554] [Reference Citation Analysis]
91 Nappi F, Giacinto O, Ellouze O, Nenna A, Avtaar Singh SS, Chello M, Bouzguenda A, Copie X. Association between COVID-19 Diagnosis and Coronary Artery Thrombosis: A Narrative Review. Biomedicines 2022;10:702. [DOI: 10.3390/biomedicines10030702] [Reference Citation Analysis]
92 Persson E, Castresana-Aguirre M, Buzzao D, Guala D, Sonnhammer ELL. FunCoup 5: Functional Association Networks in All Domains of Life, Supporting Directed Links and Tissue-Specificity. J Mol Biol 2021;433:166835. [PMID: 33539890 DOI: 10.1016/j.jmb.2021.166835] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
93 Ali FEM, Mohammedsaleh ZM, Ali MM, Ghogar OM. Impact of cytokine storm and systemic inflammation on liver impairment patients infected by SARS-CoV-2: Prospective therapeutic challenges. World J Gastroenterol 2021; 27(15): 1531-1552 [PMID: 33958841 DOI: 10.3748/wjg.v27.i15.1531] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]